International Lymphatic Disease and Lymphedema Registry

NCT01336790 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-11-22

No results posted yet for this study

Summary

The purpose of the International Lymphatic Disease and Lymphedema Patient Registry and Biorepository is to collect health information in order to study the disease classification, natural history, and impact of Lymphatic Disease, Lymphedema and Related Disorders and its treatments and medical outcomes.

Conditions

  • Lymphedema

Sponsors & Collaborators

Principal Investigators

  • Stanley G Rockson · Stanford University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01336790 on ClinicalTrials.gov